Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naitee Ting

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Biopharmaceutical Statistics|November 1, 2023
Response to Comment on "Emerging insights and commentaries - MMRM vs LOCF by Naitee Ting"Naitee Ting
Therapeutic Innovation & Regulatory Science|May 2, 2018
Statistical Interactions in a Clinical TrialNaitee Ting
Journal of Biopharmaceutical Statistics|February 27, 2023
Emerging insights and commentaries - MMRM vs LOCFNaitee Ting
Frontiers in Public Health|January 17, 2014
An Application of Graphical Approach to Construct Multiple Testing Procedures in a Hypothetical Phase III DesignBushi Wang, Naitee Ting
Journal of Biopharmaceutical Statistics|February 17, 2016
Sample size determination with familywise control of both type I and type II errors in clinical trialsBushi Wang, Naitee Ting
Pharmaceutical Statistics|June 21, 2012
A proof-of-concept clinical trial design combined with dose-ranging explorationXin Wang, Naitee Ting
Journal of Biopharmaceutical Statistics|March 8, 2018
Bayesian sample size determination for a Phase III clinical trial with diluted treatment effectYing-Ying Zhang, Naitee Ting
Statistics in Medicine|May 20, 2003
A modified large-sample approach to approximate interval estimation for a particular intraclass correlation coefficientJoseph C Cappelleri, Naitee Ting
Statistics in Medicine|June 22, 2018
Dynamic development paths for expanding a proof-of-concept study to explore dose rangeQiqi Deng, Xiaofei Bai, Naitee Ting
Journal of Biopharmaceutical Statistics|November 11, 2025
Tables, listings and figures in a clinical study report - quality or quantity?Ning Li, Yaohua Zhang, Naitee Ting
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Biopharmaceutical Statistics|November 1, 2023
Response to Comment on "Emerging insights and commentaries - MMRM vs LOCF by Naitee Ting"Naitee Ting
Therapeutic Innovation & Regulatory Science|May 2, 2018
Statistical Interactions in a Clinical TrialNaitee Ting
Journal of Biopharmaceutical Statistics|February 27, 2023
Emerging insights and commentaries - MMRM vs LOCFNaitee Ting
Frontiers in Public Health|January 17, 2014
An Application of Graphical Approach to Construct Multiple Testing Procedures in a Hypothetical Phase III DesignBushi Wang, Naitee Ting
Journal of Biopharmaceutical Statistics|February 17, 2016
Sample size determination with familywise control of both type I and type II errors in clinical trialsBushi Wang, Naitee Ting
Pharmaceutical Statistics|June 21, 2012
A proof-of-concept clinical trial design combined with dose-ranging explorationXin Wang, Naitee Ting
Journal of Biopharmaceutical Statistics|March 8, 2018
Bayesian sample size determination for a Phase III clinical trial with diluted treatment effectYing-Ying Zhang, Naitee Ting
Statistics in Medicine|May 20, 2003
A modified large-sample approach to approximate interval estimation for a particular intraclass correlation coefficientJoseph C Cappelleri, Naitee Ting
Statistics in Medicine|June 22, 2018
Dynamic development paths for expanding a proof-of-concept study to explore dose rangeQiqi Deng, Xiaofei Bai, Naitee Ting
Journal of Biopharmaceutical Statistics|November 11, 2025
Tables, listings and figures in a clinical study report - quality or quantity?Ning Li, Yaohua Zhang, Naitee Ting
Pageof 3